Clinical Trial Update: Taxotere + Cisplatin in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Taxotere (docetaxel) plus cisplatin in nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: COMPLETED